FI941053A0 - Lääkkeenä käyttökelpoinen mutatoitu kasvutekijäreseptori ja sen käyttö syövän hoidossa - Google Patents

Lääkkeenä käyttökelpoinen mutatoitu kasvutekijäreseptori ja sen käyttö syövän hoidossa

Info

Publication number
FI941053A0
FI941053A0 FI941053A FI941053A FI941053A0 FI 941053 A0 FI941053 A0 FI 941053A0 FI 941053 A FI941053 A FI 941053A FI 941053 A FI941053 A FI 941053A FI 941053 A0 FI941053 A0 FI 941053A0
Authority
FI
Finland
Prior art keywords
cancer
drug
treatment
growth factor
factor receptor
Prior art date
Application number
FI941053A
Other languages
English (en)
Swedish (sv)
Other versions
FI941053A (fi
Inventor
Norbert Redemann
Axel Ullrich
Original Assignee
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft filed Critical Max Planck Gesellschaft
Publication of FI941053A0 publication Critical patent/FI941053A0/fi
Publication of FI941053A publication Critical patent/FI941053A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI941053A 1991-09-05 1994-03-04 Lääkkeenä käyttökelpoinen mutatoitu kasvutekijäreseptori ja sen käyttö syövän hoidossa FI941053A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19914129533 DE4129533A1 (de) 1991-09-05 1991-09-05 Mutierter wachstumsfaktorrezeptor als arzneimittel und seine verwendung zur behandlung von krebs
PCT/EP1992/002058 WO1993005148A1 (de) 1991-09-05 1992-09-07 Mutierter wachstumsfaktorrezeptor als arzneimittel und seine verwendung zur behandlung von krebs

Publications (2)

Publication Number Publication Date
FI941053A0 true FI941053A0 (fi) 1994-03-04
FI941053A FI941053A (fi) 1994-04-08

Family

ID=6439926

Family Applications (1)

Application Number Title Priority Date Filing Date
FI941053A FI941053A (fi) 1991-09-05 1994-03-04 Lääkkeenä käyttökelpoinen mutatoitu kasvutekijäreseptori ja sen käyttö syövän hoidossa

Country Status (12)

Country Link
EP (1) EP0667899A1 (fi)
JP (1) JPH07502884A (fi)
CN (1) CN1071586A (fi)
AU (1) AU669857B2 (fi)
CA (1) CA2117073A1 (fi)
DE (1) DE4129533A1 (fi)
FI (1) FI941053A (fi)
MX (1) MX9205084A (fi)
NO (1) NO940778L (fi)
NZ (1) NZ244239A (fi)
PT (1) PT100844A (fi)
WO (1) WO1993005148A1 (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465623B2 (en) 1995-05-02 2002-10-15 Garvan Institute Of Medical Research GDU, a novel signalling protein
AUPN274295A0 (en) * 1995-05-02 1995-05-25 Garvan Institute Of Medical Research GDU, a novel signalling protein
US6790614B1 (en) 1999-11-19 2004-09-14 Novartis Ag Selectable cell surface marker genes
BRPI0508286B8 (pt) 2004-03-31 2021-05-25 Dana Farber Cancer Inst Inc método para determinar a probabilidade de eficácia de um inibidor da tirosina quinase egfr para tratar câncer, uso de um inibidor da tirosina quinase de egfr, sonda, kit, e, par de iniciadores

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68926888T2 (de) * 1988-01-22 1997-01-09 Zymogenetics Inc Verfahren zur Herstellung von sekretierten Rezeptoranalogen
WO1990008160A1 (en) * 1989-01-20 1990-07-26 Imperial Cancer Research Technology Ltd. Growth factor receptor-like peptides without tyrosine-kinase activity
GB9001466D0 (en) * 1990-01-23 1990-03-21 Erba Carlo Spa Extracellular form of the human fibroblast growth factor receptor
DE69031120T2 (de) * 1989-05-19 1998-01-15 Genentech Inc Her2 extrazellulare domäne
WO1991003489A1 (en) * 1989-09-08 1991-03-21 The Johns Hopkins University Structural alterations of the egf receptor gene in human gliomas

Also Published As

Publication number Publication date
WO1993005148A1 (de) 1993-03-18
AU2518592A (en) 1993-04-05
FI941053A (fi) 1994-04-08
EP0667899A1 (de) 1995-08-23
MX9205084A (es) 1993-05-01
CN1071586A (zh) 1993-05-05
DE4129533A1 (de) 1993-03-11
AU669857B2 (en) 1996-06-27
NO940778D0 (no) 1994-03-04
JPH07502884A (ja) 1995-03-30
CA2117073A1 (en) 1993-03-18
PT100844A (pt) 1994-05-31
NO940778L (no) 1994-05-04
NZ244239A (en) 1995-07-26

Similar Documents

Publication Publication Date Title
DE69233491D1 (de) Pharmazeutische Zusammensetzung enthaltend S-Nitrosolipoproteine und deren Verwendung
EG19187A (en) Quinazoline derivatives and their use as fungicide.
ITMI920528A0 (it) 14-beta idrossi-10-de acetil-baccatina iii, suoi derivati, loro preparazione ed impiego terapeutico
ATA901392A (de) Hepatitis-c-diagnosemittel und -impfstoffe
EP0498268A3 (en) 5-oxo-l-proline derivatives and pharmaceutical use thereof
FI944600A0 (fi) Imidatsol-4-yylipiperidiinijohdannaisia, niiden valmistus ja niiden käyttö terapiassa
DE69223266D1 (de) Peptidderivate und deren Verwendung
IT8768027A0 (it) Derivati di 1 piperazinil pirimidina loro preparazione e impiego in terapia e cosmesi
DE69230654D1 (de) Commiphora-Mukul-Extrakte und deren therapeutische Verwendung
GB9022368D0 (en) Materials useful in human and veterinary medicine
DE68910113T2 (de) Wachstuminhibierendes mittel und dessen verwendung.
FI892428A (fi) Katalysaattori ja sen käyttö polyolefiinien valmistamiseen
DE3879811D1 (de) Pharmazeutische zusammensetzung und ihre verwendung.
ZA917853B (en) 2-aminopyrimidine-4-carboxamide derivatives,their preparation and their use in therapy
FI940775A0 (fi) alfa-fenyyli-isoseriinijohdannaisten valmistusmentelmä ja niiden käyttö
FI941053A0 (fi) Lääkkeenä käyttökelpoinen mutatoitu kasvutekijäreseptori ja sen käyttö syövän hoidossa
FI973185A0 (fi) Melatoniinin käyttö lääkeriippuvuudesta kärsivien potilaiden hoitoon
DE69210474T2 (de) Medizinisch-chirurgische Hygieneartikel und Materialien
IL91451A0 (en) Pharmaceutical compositions comprising azapiron compounds and their use in the treatment of addiction
ZA924127B (en) New hetaryloxy-beta-carbolines,their production and use in pharmaceutical agents
PT100033A (pt) Produtos farmaceuticos contendo granisetron e dexametasona util no tratamento de nauseas e vomitos
ZA911956B (en) 9-chlor-prostaglandin-beta-cyclodextrin-clathrates and their use as medicinal substances
DE59108548D1 (de) Implantierbare Geräte und Materialien
AU1745092A (en) Thiazolidine derivatives and their use in therapy
DE69121210D1 (de) Therapeutische verwendung des fibroblastenwachstumsfaktors

Legal Events

Date Code Title Description
FD Application lapsed